Clinical Trial

An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face

Name: An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face — clinical trial record (NCT07729579)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The research study will evaluate how the body absorbs and reacts to reformulated Levulan Kerastick when applied to actinic keratosis lesions (AKs) on the skin of the forearms or face followed by photodynamic therapy (PDT), a treatment that uses application of blue light.

Trial Details

NCT Number	NCT07729579
Lead Sponsor	Sun Pharmaceutical Industries Limited
Conditions	Actinic Keratosis (AK)
Enrollment	48 participants
Start Date	2026-08-04
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-13